Biolase BIOL reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Biolase missed estimated earnings by 46.77%, reporting an EPS of $-0.91 versus an estimate of $-0.62.
Revenue was up $3.10 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.09 which was followed by a 16.67% increase in the share price the next day.
Here's a look at Biolase's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.68 | -0.75 | -1 | |
EPS Actual | -0.77 | -0.75 | -0.50 | -0.5 |
Revenue Estimate | 9.01M | 11.97M | 8.78M | 8.31M |
Revenue Actual | 10.17M | 12.41M | 9.53M | 9.13M |
To track all earnings releases for Biolase visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.